NCT01187927View on ClinicalTrials.gov

Drug Use Investigation for Cervarix®

CompletedOBSERVATIONAL

Enrollment

1,230

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Infections, Papillomavirus

Interventions

BIOLOGICAL

Cervarix®

Administered according to the prescribing information in the locally approved label by the authorities.

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01187927 - Drug Use Investigation for Cervarix® | Biotech Hunter | Biotech Hunter